REPLIGEN CORP (RGEN) Free cash flow 2016–2025
REPLIGEN CORP (RGEN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$93.9MFY2025 · since FY2016: $3.2M → $93.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $93.9M | -37.3% |
| FY2024 | $149.7M | +92.7% |
| FY2023 | $77.7M | -10.9% |
| FY2022 | $87.2M | +68.0% |
| FY2021 | $51.9M | +29.3% |
| FY2020 | $40.2M | -17.5% |
| FY2019 | $48.7M | +120.1% |
| FY2018 | $22.1M | +84.5% |
| FY2017 | $12.0M | +275.4% |
| FY2016 | $3.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RGEN financial trends
RGEN RevenueRGEN Net incomeRGEN Net marginRGEN Gross profitRGEN Gross marginRGEN Operating incomeRGEN Operating marginRGEN Operating cash flowRGEN Capital expendituresRGEN Return on equityRGEN Stock buybacksRGEN Dividends paidRGEN Total assetsRGEN Total liabilitiesRGEN Shareholders’ equityRGEN overview →